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The Difficulty of using a Biological Marker for Alcohol Use: A Recent 
Historical Overview 
David Adler 
According to the National Health Interview Survey from 2011, 52% of adults over 
the age of 18 in the United States are regular drinkers [1]. However, because of the 
difficulty of defining alcoholism scientifically, there are few widespread statistics 
regarding the proportion of this group who are problem drinkers. This brings us to the 
field of science. Scientists have wanted to set a biological marker on alcoholism to track 
alcohol use and determine what separates a regular drinker from an alcoholic. A 
biological marker could increase the effective surveillance of rehabilitation, gather data 
from patients more effectively, help in overcoming patient denial and treat alcoholism 
scientifically and objectively. However, while some tests have shown more consistency 
than others, there still does not exist an ideal biological marker for alcoholism and 
related treatment. The complexity of chemicals involved and patient genetic 
predisposition make this pursuit even more complex. In this paper I will discuss the 
more prominent and significant biological markers used in the past and present to 
detect alcohol use, explain their association to alcohol consumption and their 
functionality in the field.  
 
Trait Markers 
 
 Biological markers indicate the progress or state of a condition by gathering 
information about biochemical substances within the body. Trait markers reveal a 
subject’s inherited risk towards alcohol consumption (i.e. family genetics) [2]. A useful 
trait marker molecule must satisfy three criteria: Passed down by genes, associated 
with the disease in question and should be independent of the subject’s disease status 
as explained by Ratsma et al [3]. State markers, on the other hand, are measures 
revealing the short-term of substance intake of the patient while trait markers reveal 
genetic inheritance of the patient. Ideally, a good biological marking test would require 
the combination of the two markers. 
 The early research of trait markers began with a focus on familial alcohol use 
divided into a subject’s history of positive or negative familial alcoholism (FHP & FHN 
respectively) [4]. This knowledge was used in combination with ethanol sensitivity 
testing and Monoamino Oxidase activity but many inconsistencies in methodology over 
different tests and conflicting results created unnecessary speculation and lowered 
interest for further research. For example some studies showed that FHP subjects were 
less sensitive to small effects of alcohol than FHN subjects [5] [6]. However, other 
studies found opposite data or even neutral findings [7] [8].  
 Results from Tabakoff et al [9] depicted lower platelet adenylate cyclase (AC) 
activity in alcoholics, however, Devor et al [10] replicated the study with no significant 
link. Recently researchers observed the same pattern as Tabakoff et al but noticed that 
other drug consumption affected AC activity [11] making AC an unsuitable measure 
without further research. There has also been an observed link between people who are 
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alcohol dependent and have lower levels of the neurotransmitter, gamma-aminobutryric 
acid (GABA), than do non-alcohol-dependent people [3]. But because it is not 
independent of the status of the disease it therefore doesn’t match the criteria of a good 
trait marker. Dopamine reception in the 1990s was found to have an A1 allele 
associated with severe form of alcoholism [12] and as some research suggests there is 
lower level of dopamine receptor activity with alcoholic men [3]. However, this conflicts 
with findings from Balldin et al [13] that demonstrated that alcoholics showed an 
elevated response to dopamine after a short withdrawal period, making dopamine an 
unlikely trait marker candidate.  
As of now, the measurement of serotonin and beta-endorphins shows the 
greatest potential for clinical widespread use. The neurotransmitter beta-endorphin 
functions as an opioid to produce natural pain relief. Studies have found that alcoholics 
have lower levels of beta-endorphin than non-alcoholics [14], however, because it is not 
independent of the status of the disease for the person, I does not fit the criteria. 
Research has shown lower levels of the amino acid tryptophan, which produces the 
neurotransmitter serotonin, with those who consume excessive alcohol [3]. Research 
into serotonin transportation has shown higher serotonin transporter activity with 
alcoholics and with children of alcoholics than non-alcoholics [15], thus fitting the criteria 
of a good trait marker. While many trait markers for alcoholism exist, few of them meet 
the necessary criteria but there is some promise in further research into serotonin and 
beta-endorphins. 
 
State Markers 
 
 Our discussion then moves to that of state markers. The most common and 
important state marker is the testing of ethanol levels in the bloodstream most 
commonly tested with a Breathalyzer for a subject's Blood Alcohol Content (BAC) or 
through urine screening. However, the body quickly detoxifies ethanol and urine 
screening is unable to both represent chronic/long term and recent drinking. Thus, 
ethanol is only useful for short-term use indication and is used for mostly police and 
professional settings and screenings [17].  
 Clinicians currently measure the activity of liver enzymes and red blood cell 
volume. One measure they use is that of the liver enzyme gamma-glutamyltranferase 
(GGT). This glycoprotein aids in digestion and is involved in bile production. Elevated 
GGT levels can be an early indicator of liver disease but it is not that sensitive to alcohol 
consumption and is only useful with consumption of heavy drinkers. GGT levels are also 
affected by digestive disease [2]. Another widespread measure was that of the mean 
corpuscular volume (MCV) of red blood cells. This measure shows an alcoholic’s MCV 
stays high regardless of abstinence but since other conditions affect MC, it is not an 
ideal state marker [18]. In addition, research in the 1990s indicated that the use of other 
drugs affected MCV and GGT levels [19].   
Still used today are both the enzymes asparate Aminotrasnferace (AST) and 
alanine aminotransferace (ALT), however, they represent more an indication of liver 
disease than for alcohol use. Research from the 1990s has shown that when healthy 
individuals binge drink their AST and ALT levels in the blood increase [20]. However, 
AST is found in other internal organs including the kidney and brain. Thus, these 
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enzymes are more to confirm knowledge of liver damage than used as a state marker 
and they are less sensitive with subjects under 30 and over 70 [1] [4]. These enzymes 
have not been furthered researched as of today. 
A very well characterized indicator is that of the Carbohydrate-Deficient 
Transferrin (CDT) that is involved in the transport and delivery of iron in the body and 
shown [21] to have higher levels in alcoholics. CDT is a good indicator in evaluating 
alcoholism treatment because of its half-life of 14 days [22].  However, the successful 
findings of CDT in the past does not match up to our present concerns that show it is 
too specific of a measure and is too inclined to give false negative readings. However, 
recent improvements have developed agents that can specifically detect CDT [23] and it 
has increased success when paired it with GGT tests [24]. CDT remains a good 
indicator of heavy alcohol consumption.  
Some of the newer state biological markers include Plasma Sialic Acid Index of 
ofapolipoprotein J (SIJ) and the compound acetaldehyde show potential. SIJ transports 
lipids into the blood and has shown that sialic acid particles decrease after alcoholic 
consumption. It is more specific than CDT because it has four times the acid chains as 
CDT thus it shows promise for further testing [25].  Tests using high-performance liquid 
chromatography, known as whole blood-associated acetaldehyde assay (WBAA), have 
given very specific and sensitive results [21] but with FDA approval pending it still 
requires more legitimization and credibility despite its amazing potential.  
The difficulty with choosing an effective state marker includes the effect of other 
drugs, gastro-intestinal diseases involved and differing subject usage levels over time 
that can affect the activity of relevant enzymes. So unfortunately no state marker exists 
that is durable against each of these informal criteria but research in SIJ, acetaldehyde 
and CDT paired with GGT show good potential in the field. 
In conclusion, there is no single test to accurately represent the long term and 
short-term consumption of alcohol. The best device is to use a combination of 
consistent state and trait marker tests in supplement with a questionnaire. A 
questionnaire poses threats to internal validity through the subject’s poor memory recall 
and deliberate falsification of data but it consistently serves as standard measure of 
alcohol consumption. There are also many more possible biological markers of alcohol 
use that I have not listed but each fraught with their own unique set of problems. Similar 
to the position of scientists in the 1990s, there is much more research needed in order 
to exact a better combination of measures to develop an equally specific and sensitive 
marker. Biomarkers will help to objectify definitions of alcohol abuse that the DSM-IV 
can only do with subjective description. Thus research into these biological markers will 
not only develop testing that will help to understand the risk of genetic factors but also 
aid in the treatment of alcoholics through a greater understanding of alcohol use/abuse 
and a more efficient surveillance of recovery. 
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